Developing a novel dual PI3K-mTOR inhibitor from the prodrug of a metabolite.
Zhou Y, Zhang G, Wang F, Wang J, Ding Y, Li X, Shi C, Li J, Shih C, You S.
Zhou Y, et al. Among authors: wang f, wang j.
Onco Targets Ther. 2017 Oct 20;10:5077-5087. doi: 10.2147/OTT.S142492. eCollection 2017.
Onco Targets Ther. 2017.
PMID: 29118584
Free PMC article.